Multi-Modal Contrast Agent For Medical Imaging
AssigneeBoard of Trustees of Michigan State University
InventorsAnna V. MOORE, Lorenzo F. SEMPERE, Neil M. ROBERTSON
Life of this patent
Estimating the term…
Abstract
A nanoparticle is provided. The nanoparticle includes a magnetic core including a magnetic nanocrystal, a fluorophore coupled to the magnetic core, at least one chelating compound coupled to the magnetic core, the at least one chelating compound being a compound that chelates copper-64 (64Cu), a compound that chelates technetium-99m (99mTc), or a combination thereof, and an iodine chelator coupled to the magnetic core. Methods of making the nanoparticle and of using the nanoparticle as a multi-modal contrast agent are also provided.
Claims22
A nanoparticle comprising:
- a magnetic core comprising a magnetic nanocrystal;
- a fluorophore coupled to the magnetic core;
- at least one chelating compound coupled to the magnetic core, the at least one chelating compound being a compound that chelates copper-64 (64Cu), a compound that chelates technetium-99m (99mTc), or a combination thereof;
- and
- an iodine chelator coupled to the magnetic core.
A nanoparticle comprising:
- a single magnetic core having a diameter of greater than or equal to about 20 nm to less than or equal to about 30 nm, the single magnetic core comprising at least one iron oxide nanocrystal;
- a coating at least partially covering the single magnetic core, the coating comprising dextran cross-linked with aminated epichlorohydrin;
- and
- an iodine chelator coupled to the aminated epichlorohydrin, the iodine chelator comprising thyroxine (T4), triiodothyronine (T3), or a combination thereof,
- wherein the nanoparticle is configured to provide contrast for magnetic resonance imaging (MRI), magnetic particle imaging (MPI), computed tomography (CT), and X-ray imaging.
A method of imaging at least one of a tissue or a metabolic process in a subject, the method comprising:
- administering to the subject a safe and effective amount of a composition comprising a contrast agent, wherein the contrast agent associates with the at least one of the tissue or the metabolic process, the contrast agent comprising:
- a magnetic core comprising a magnetic nanocrystal,
- a fluorophore coupled to the magnetic core,
- at least one chelating compound coupled to the magnetic core, the at least one chelating compound being a compound that chelates copper-64 (64Cu), a compound that chelates technetium-99m (99mTc), or a combination thereof;
- and
- an iodine chelator coupled to magnetic core;
- performing at least one of magnetic resonance imaging (MRI), magnetic particle imaging (MPI), fluorescence (FL) imaging, photoacoustic (PA) imaging, ultrasound (US) imaging, positron emission tomography (PET), single-photon emission computed tomography (SPECT), X-ray imaging, or computed tomography (CT);
- and
- generating an image of the tissue or the metabolic process with contrast provided by the contrast agent.
Dependencies are inferred from the claim text.